Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Pharmaceutical

Lundbeck

Charl Van Zyl

Claus Thomsen

Maria Alfaiate

Michala Fischer-Hansen

Dianne Hol

Tine Østergaard Hansen

Johan Luthman

Joerg Hornstein

Thomas Gibbs

Lars Bang

The Research and Development team at Lundbeck focuses on pioneering innovative treatments for psychiatric and neurological disorders. This highly specialized team conducts advanced research, develops novel drug compounds, and leverages cutting-edge technologies, including AI and digital health solutions, to enhance therapeutic outcomes. Their collaborative efforts aim to expedite the delivery of effective pharmaceuticals that significantly improve the quality of life for patients worldwide.

Research and Development

Leadership Team

Information Technology and Data Management

Sales and Marketing

Research and Development

About

Team members

Other teams at Lundbeck

Leadership Team

Information Technology and Data Management

Sales and Marketing